ZDY-30998-88308
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 490 / MI
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-14
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Registered in v-safe
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
-
2021-05-05
Dose 2 — Pfizer-BioNTech
- 2021-05-05
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-07
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-06-18
- 2021-08-06
-
2022-05-08
Survey response — 12 months, dose 2MedDRA: Malignant melanoma, SARS-CoV-2 test positive, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Melanoma, tested positive for COVID · Healthcare visit (other): SurgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-05-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-14 | Pfizer-BioNTech | |
| 2 | 2021-05-05 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-08 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | Malignant melanoma | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release